Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
|Articles|March 29, 2023
Video: Tips for Medication Management During Ramadan
Author(s)Lauren Biscaldi, MS
Pharmacists can provide support and guidance to patients during their month of fasting.
Advertisement
Rania El-Desoky, PharmD, a lecturer at the University of Western Australia, joined Drug Topics at the APhA 2023 Annual Meeting to share important insights and best practices around managing patients with certain medical conditions during the month of Ramadan.
Advertisement
Related to this article
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves First Generic for Climara Pro Hormone Therapy Patch
2
FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B
3
Harms of Public Health Measures Overlooked in COVID-19 Policy Reviews
4
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
5